Sponsor content
330 result(s) found, displaying 71 to 80
-
Prescription medicine decision summaryLokelma (sodium zirconium cyclosilicate hydrate) was approved for the treatment of hyperkalaemia in adult patients. Lokelma binds to potassium in the gut and is used to treat high levels of potassium in the blood.
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate, sitagliptin phosphate monohydrate.
-
Designation or determinationProvisional determination
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules 500mcg/2ml.
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.25mg/mL nebulizer suspension.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.25 mg/ml nebuliser suspension.